Nanostring cosmx reagents
Ended Awarded Last action
- Contract number
- 75N91024F00001
- Awardee
-
Nanostring Technologies, Inc. UEI JEKKWSBFM2K4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $21,440
Award facts
- Contract value 100% obligated
- $21,440.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339999 All Other Miscellaneous Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98109, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a $21.44K firm fixed price BPA (Blanket Purchase Agreement) call to Nanostring Technologies, Inc. on March 15, 2024, for nanoString CosMx reagents, with an ultimate completion date of April 14, 2024. This contract represents a delivery order under an existing blanket purchase agreement vehicle and requires no set-aside designation. Nanostring Technologies, a publicly traded provider of advanced genomic analysis platforms and life science tools, will supply specialized reagents to support the National Cancer Institute's molecular diagnostics and translational research initiatives. The vendor's place of performance is Seattle, Washington.
Nanostring Technologies has an established history of supporting federal biomedical research through multiple prime and subcontract awards across agencies including the National Institutes of Health, Department of Veterans Affairs, and Department of Defense. The company specializes in providing genomic analysis equipment, reagents, assays, and consumables compatible with their nCounter Analysis Systems and GeoMx Digital Spatial Profiler platforms. This award reflects the National Cancer Institute's continued reliance on Nanostring's proprietary technologies to enable multiplexed, digital detection and counting of nucleic acids, proteins, and cells for cancer research and diagnostic applications.
Quick answers
Who was awarded contract 75N91024F00001?
75N91024F00001 was awarded to Nanostring Technologies, Inc. by National Cancer Institute (National Institutes of Health) on March 15, 2024.
How much is contract 75N91024F00001 worth?
The government has obligated $21,440 on 75N91024F00001.
Is contract 75N91024F00001 an order under another contract?
Yes. 75N91024F00001 is a BPA call under HHSN263201400050B, a blanket purchase agreement.
Was contract 75N91024F00001 competed?
The extent of competition for 75N91024F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award